Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma

被引：0
|
作者：
Pinto, Elisa [1 ]
Pelizzaro, Filippo [1 ]
Vitale, Alessandro [1 ]
Giannini, Edoardo [2 ]
Trevisani, Franco [3 ]
Farinati, Fabio [1 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Univ Genoa, Genoa, Italy
[3] Univ Bologna, Bologna, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-308
引用
收藏
页码：S511 / S512
页数：2
相关论文
共 50 条
  • [21] Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
    Decaens, T
    Roudot-Thoraval, F
    Bresson-Hadni, S
    Meyer, C
    Gugenheim, J
    Durand, F
    Bernard, PH
    Boillot, O
    Boudjema, K
    Calmus, Y
    Hardwigsen, J
    Ducerf, C
    Pageaux, GP
    Dharancy, S
    Chazouilleres, O
    Dhumeaux, D
    Cherqui, D
    Duvoux, C
    LIVER TRANSPLANTATION, 2005, 11 (07) : 767 - 775
  • [22] Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma
    Kinugasa, Hideaki
    Nouso, Kazuhiro
    Takeuchi, Yasuto
    Yasunaka, Tetsuya
    Onishi, Hideki
    Nakamura, Shin-ichiro
    Shiraha, Hidenori
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Ikeda, Fusao
    Miyake, Yasuhiro
    Takaki, Akinobu
    Yamamoto, Kazuhide
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (04) : 421 - 426
  • [23] Predictors of Mortality in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemoembolization
    Barman, Pranab
    Sharma, Pratima
    Krishnamurthy, Venkat
    Willatt, Jonathon
    McCurdy, Heather
    Moseley, Richard H.
    Su, Grace L.
    HEPATOLOGY, 2013, 58 : 1271A - 1271A
  • [24] Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma
    Hideaki Kinugasa
    Kazuhiro Nouso
    Yasuto Takeuchi
    Tetsuya Yasunaka
    Hideki Onishi
    Shin-ichiro Nakamura
    Hidenori Shiraha
    Kenji Kuwaki
    Hiroaki Hagihara
    Fusao Ikeda
    Yasuhiro Miyake
    Akinobu Takaki
    Kazuhide Yamamoto
    Journal of Gastroenterology, 2012, 47 : 421 - 426
  • [25] Transarterial chemoembolization (TACE) combined with donafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A real-world clinical study.
    Zhang, Weihong
    Zhu, Bowen
    Tang, Yiyang
    Xue, Miao
    Wu, Yanqin
    Zhao, Yue
    Fan, Wenzhe
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization
    Wu, Zhi-Juan
    Xie, Yin-Fa
    Chang, Xu
    Zhang, Lin
    Wu, Hui-Yong
    Liu, Ji-Bing
    Zhang, Jian-Xin
    Sun, Peng
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [27] Predictors of survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Doan, P. L.
    O'Neil, B. H.
    Moore, D. T.
    Bernard, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Barman, Pranab M.
    Sharma, Pratima
    Krishnamurthy, Venkat
    Willatt, Jonathon
    McCurdy, Heather
    Moseley, Richard H.
    Su, Grace L.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (11) : 2821 - 2825
  • [29] Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Pranab M. Barman
    Pratima Sharma
    Venkat Krishnamurthy
    Jonathon Willatt
    Heather McCurdy
    Richard H. Moseley
    Grace L. Su
    Digestive Diseases and Sciences, 2014, 59 : 2821 - 2825
  • [30] Transarterial chemoembolization of hepatocellular carcinoma
    Huppert, Peter
    RADIOLOGE, 2022, 62 (03): : 225 - 233
12345